Journal article
New Tracers PET in Head and Neck Squamous Cell Carcinoma
PET clinics, Vol.7(4), pp.431-441
10/2012
DOI: 10.1016/j.cpet.2012.06.009
PMID: 27157649
Abstract
PET is commonly used in the evaluation and posttreatment management of head and neck squamous cell carcinoma. Although [18F]fluorodeoxyglucose is the most commonly used radiopharmaceutical, many other radiopharmaceuticals are under investigation to assess particular biologic characteristics such as hypoxia and tumor repopulation. In this review, the authors discuss new PET tracers that allow the biologic profiling of head and neck squamous cell carcinomas, including [18F]fluoromisonidazole, [18F]fluorothymidine, [18F]fluoromethyltyrosine, and epidermal growth factor receptor biomarkers.
Details
- Title: Subtitle
- New Tracers PET in Head and Neck Squamous Cell Carcinoma
- Creators
- Tony J.C Wang - Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, 622 West 168th Street, New York, NY 10032, USAYusuf Menda - Department of Radiology, University of Iowa, 200 Hawkins Drive, Iowa City, IA, USASimon K Cheng - Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, 622 West 168th Street, New York, NY 10032, USACheng-Chia Wu - Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, 622 West 168th Street, New York, NY 10032, USANancy Y Lee - Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
- Resource Type
- Journal article
- Publication Details
- PET clinics, Vol.7(4), pp.431-441
- Publisher
- Elsevier Inc
- DOI
- 10.1016/j.cpet.2012.06.009
- PMID
- 27157649
- ISSN
- 1556-8598
- eISSN
- 1879-9809
- Language
- English
- Date published
- 10/2012
- Academic Unit
- Radiology; Radiation Oncology
- Record Identifier
- 9984047997902771
Metrics
10 Record Views